Cardiff University begins study of schizophrenia therapy
The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor - News - PharmaTimes
Source: pharmatimes.com
Stay updated with breaking news from Professors Simon Ward. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor - News - PharmaTimes